A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases.

scientific article

A review of scoring systems for ocular involvement in chronic cutaneous bullous diseases. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P6179Dimensions Publication ID1104089366
P356DOI10.1186/S13023-018-0823-5
P2888exact matchhttps://scigraph.springernature.com/pub.10.1186/s13023-018-0823-5
P932PMC publication ID5964694
P698PubMed publication ID29789014

P50authorBrendon W H LeeQ88776716
P2093author name stringMinas T Coroneo
Dedee F Murrell
Jeremy C K Tan
Melissa Radjenovic
P2860cites workBlepharospasm and apraxia of eyelid opening associated with anti-Hu paraneoplastic antibodies: a case report.Q50771877
Linear IgA bullous disease limited to the eye: a diagnostic dilemma: response to intravenous immunoglobulin therapy.Q51077004
Essential shrinking of the conjunctiva in a hereditary affection allied to epidermolysis bullosa.Q51357506
[Conjunctival mixed injection with membrane development. Ocular involvement in epidermolysis bullosa hereditaria generalisata atrophicans]Q52953405
Ocular and oral grading of mucous membrane pemphigoid.Q53091231
The Birmingham Epidermolysis Bullosa Severity score: development and validation.Q53105225
Severity score indexes for blistering diseasesQ24604349
In vivo confocal microscopy in dry eye disease and related conditionsQ27026571
The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EBQ28274402
A new method for measuring progression in patients with ocular cicatricial pemphigoidQ31042117
In vivo confocal microscopy of ocular cicatricial pemphigoid.Q33238457
The eye in epidermolysis bullosaQ33655319
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigusQ33692698
Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts.Q34067962
Essential Shrinkage of the Conjunctiva in a Case of Probable Epidermolysis Bullosa Dystrophica.Q34227217
Revisiting Sjögren's syndrome in the new millennium: perspectives on assessment and outcome measures. Report of a workshop held on 23 March 2000 at Oxford, UK.Q34401060
Eye involvement in autoimmune blistering diseasesQ34436707
Epidermolysis bullosa dystrophica inversa, a review and case reportQ34480150
Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa RegistryQ34549790
The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicatorsQ34570285
Inherited epidermolysis bullosa: updated recommendations on diagnosis and classificationQ34660939
Validation of a fornix depth measurer: a putative tool for the assessment of progressive cicatrising conjunctivitisQ34996874
Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI).Q35072028
Definitions and outcome measures for mucous membrane pemphigoid: recommendations of an international panel of experts.Q35466213
Mucous membrane pemphigoid and pseudopemphigoidQ35623517
In-vivo Confocal Microscopy for the Diagnosis of Mucous Membrane PemphigoidQ35689307
Upper and lower conjunctival fornix depth in healthy white caucasian eyes: a method of objective assessment.Q36071599
Ocular surface findings in Hallopeau-Siemens subtype of dystrophic epidermolysis bullosa: report of a case and literature reviewQ36097683
Autoimmune bullous diseases: ocular manifestations and managementQ36237529
Immunobullous Diseases With Ocular InvolvementQ36264266
Characterization of Corneal Involvement in Eyes With Mucous Membrane Pemphigoid by In Vivo Confocal MicroscopyQ36343259
Introducing a novel Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) in pemphigusQ36746034
Meibomian gland disease. Classification and grading of lid changesQ36791267
Clinical features and in vivo confocal microscopy assessment in 12 patients with ocular cicatricial pemphigoidQ36951118
Ocular manifestations of blistering diseasesQ37087685
Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissuesQ37584740
Ophthalmic involvement in inherited epidermolysis bullosaQ37640788
In vivo confocal microscopy of the ocular surface: from bench to bedsideQ37649719
Paraneoplastic conjunctival cicatrization: two different pathogenic typesQ37666173
Cicatricial changes in ocular pemphigus.Q37697899
Defining the limits of normal conjunctival fornix anatomy in a healthy South Asian populationQ37709776
Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current managementQ37940584
Cicatricial pemphigoid and erythema multiformeQ37945609
Ocular and oral mucous membrane pemphigoid (cicatricial pemphigoid).Q37964156
Pemphigoid diseasesQ38067153
Diagnosis and classification of autoimmune blistering diseasesQ38179185
The spectrum of oculocutaneous disease: Part I. Infectious, inflammatory, and genetic causes of oculocutaneous disease.Q38205313
Prospective study of ocular manifestations of pemphigus and bullous pemphigoid identifies a high prevalence of dry eye syndromeQ38344121
Autoimmune bullous diseases with skin and eye involvement: Cicatricial pemphigoid, pemphigus vulgaris, and pemphigus paraneoplasticaQ38745285
Ocular manifestations of genetic skin disordersQ38745302
Defining Ocular Surface Disease Activity and Damage Indices by an International Delphi ConsultationQ38817004
New Grading System and Treatment Guidelines for the Acute Ocular Manifestations of Stevens-Johnson SyndromeQ38864164
Ocular involvement in pemphigus vulgaris - a retrospective study of a large Spanish cohortQ38884157
The 2016 Bowman Lecture Conjunctival curses: scarring conjunctivitis 30 years on.Q39096598
Ocular pemphigoidQ39763850
Epidermolysis bullosa acquisita. Report of three cases and review of all published casesQ39893277
The National Epidermolysis Bullosa RegistryQ40658492
Review of ophthalmic findings in 204 patients with epidermolysis bullosaQ40702465
The Frequency of Signs of Meibomian Gland Dysfunction in Children with Epidermolysis BullosaQ40910017
The Spectrum of Epidermolysis Bullosa AcquisitaQ41128759
Ocular cicatricial pemphigoid and ocular manifestations of pemphigus vulgaris.Q41575935
Ocular Changes in Epidermolysis Bullosa LetalisQ41919319
Paraneoplastic pemphigus: an uncommon cause of chronic cicatrising conjunctivitisQ42140711
Corneal involvement in epidermolysis bullosa simplexQ42472560
Genetic Implications of Oculocutaneous DisordersQ43093412
Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoidQ43789787
Instrument for scoring clinical outcome of research for epidermolysis bullosa: a consensus-generated clinical research toolQ43968959
Medial canthal keratinisation (MCK): a diagnostic sign of ocular cicatricial pemphigoidQ44219204
Cutaneo-muco-oculoepithelial syndromesQ45179586
Ocular involvement in pemphigus vulgaris.Q45228944
Skin diseases and the dry eye.Q45297995
Eyelid skin involvement in pemphigus foliaceus.Q46898729
Bilateral corneal melting in a patient with paraneoplastic pemphigus.Q49065625
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P921main subjectvesiculobullous skin diseaseQ7923229
epidermolysis bullosaQ923020
eye diseaseQ3041498
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)83
P577publication date2018-05-22
P1433published inOrphanet Journal of Rare DiseasesQ15756117
P1476titleA review of scoring systems for ocular involvement in chronic cutaneous bullous diseases
P478volume13

Search more.